Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Shire PLC    SHP   JE00B2QKY057

SHIRE PLC (SHP)

Delayed Quote. Delayed  - 09/29 05:35:10 pm
5061 GBp   -0.92%
09/28 INSMED INCORPOR : Bridgewater-based biopharma appoints chief commerc..
09/28 Insmed Appoints Roger Adsett as Chief Commercial Officer
09/28 SHIRE : *hsbc cuts shire to 'hold' ('buy') - target 5,200 (5,250) pe..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Shire PLC : Shire Buys 50,953 Own Shares to Hold in Treasury

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2013 | 09:57am CEST

LONDON--Biopharmaceutical company Shire PLC (SHP.LN), said Friday it purchased 50,953 of its ordinary shares of 5 pence each on February 21, through both direct purchases of Ordinary Shares and through the purchase of Ordinary Shares underlying ADRs.

MAIN FACTS:

-The purchased shares will be held as treasury shares

-The highest and lowest price paid for the directly acquired Ordinary Shares was 2083.00 pence per share and 2047.00 pence per share respectively and for those Ordinary Shares acquired through the purchase of ADRs was 3148.50 cents per share and 3139.33 cents per share respectively.

-Shire shares at 0840 GMT traded up 5.0 pence, or 0.2%, at GBP20.77, valuing the company at GBP11.55 billion.

-Write to Razak Musah Baba at razak.baba@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIRE PLC
09/28 INSMED INCORPORATED : Bridgewater-based biopharma appoints chief commercial offi..
09/28 Insmed Appoints Roger Adsett as Chief Commercial Officer
09/28 SHIRE : *hsbc cuts shire to 'hold' ('buy') - target 5,200 (5,250) pence
09/26 SHIRE : *hsbc cuts shire to 'hold' ('buy') - target 5,250 (5,400) pence
09/26 *TRADERS : Hsbc cuts shire to 'hold' ('buy')
09/23DJSHIRE : Files 8K - Other Events
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
09/23DJSHIRE : Files 8K - Entry Into Definitive Agreement
09/23 SHIRE : Closes Public Offering of ...
09/23 SHIRE : Closes Public Offering of Senior Notes
More news
Sector news : Pharmaceuticals - NEC
02:40pDJGLAXOSMITHKLINE : Appoints New Consumer Healthcare Chief
10:26aDJNOVO NORDISK A/S : to Cut 1,000 Jobs Amid Growing Competition -- Update
09/28DJINTRA CELLULAR THERAPIES : Shares Plunge After Disappointing Drug Trial Results
09/28DJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
09/28 Monsanto ally Novozymes sees opportunity, risk in Bayer merger
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
11:51a Shire Cedes Biosimilar Field
09/27 Shire returns rights to Humira biosimilar to Momenta Pharma
09/22 Third Avenue Value Fund 3Q16 Commentary
09/22 Sarepta Turns New Leverage Point For Aspiring Biotechs
09/21 Allergan Sparks A Second Liver Disease Craze
Advertisement
Financials ($)
Sales 2016 11 046 M
EBIT 2016 3 772 M
Net income 2016 1 471 M
Debt 2016 20 006 M
Yield 2016 0,44%
P/E ratio 2016 29,57
P/E ratio 2017 16,42
EV / Sales 2016 7,24x
EV / Sales 2017 4,91x
Capitalization 59 990 M
More Financials
Chart SHIRE PLC
Duration : Period :
Shire PLC Technical Analysis Chart | SHP | JE00B2QKY057 | 4-Traders
Full-screen chart
Technical analysis trends SHIRE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 79,7 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Jeffrey Poulton Chief Financial Officer & Executive Director
Philip J. Vickers Global Head-Research & Development
David R. Ginsburg Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE PLC9.47%59 990
JOHNSON & JOHNSON16.23%326 636
ROCHE HOLDING LTD.-12.41%217 190
NOVARTIS AG-10.14%212 589
PFIZER INC.5.30%206 172
MERCK & CO., INC.19.84%175 038
More Results